Omepraxole and ocular damage

BMJ

Volumn 316, Issue 7124, 1998, Pages 67-

  Riordan Eva, Paul ^a   Sanders, Michael D ^b   Lessell, Simmons ^c   Sachs, George ^d   Schönhöfer, Peter S ^e  

^a Farnborough Hospital   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Zentralkrankenhaus Sankt Jürgen Strasse   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007708291     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7124.67     Document Type: Letter

References (7)

1. Schönhöfer P, Werner B, Tröger U Ocular damage associated with proton pump inhibitors. BMJ 1997; 314: 1805. (21 June.)
2. Burde RM Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993; 116: 759–764.
3. Hayreh SS, Joos KM, Podhajsky PA, Long CR Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 188:766-80.
4. Schönhöfer P, Werner B, Tröger U Ocular damage associated with proton pump inhibitors. BMJ 1997; 314: 1805. (21 June.)
5. Schönhöfer P, Werner B, Tröger U Ocular damage associated with proton pump inhibitors. BMJ 1997; 314: 1805. (21 June.)
6. Schlaeppi B, Roncari G, Zahn P Vascular toxicity in dogs associated with overdoses of a novel benzodiazepine receptor partial agonist. Arch Toxicol 1991; 65: 73–80.
7. Meeuwisse EJM, Groen FC, Dees A, Smit GH, Ottervanger JP Lethargy with omeprazole. BMJ 1997; 314: 481.